XML 25 R8.htm IDEA: XBRL DOCUMENT v3.25.4
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated other comprehensive (loss) income
Accumulated deficit
Treasury stock
Non-controlling interests
 [1]
Beginning balance (in shares) at Dec. 31, 2022   153,286,000          
Beginning balance at Dec. 31, 2022 $ 295,373 $ 1,533 $ 1,409,578 $ (101,231) $ (999,401) $ (14,737) $ (369)
Beginning balance (in shares) at Dec. 31, 2022           7,063,000  
Increase (Decrease) in Stockholders' Equity              
Net income (loss) attributable to USA TODAY Co. (27,894)       (27,791)   (103)
Other comprehensive income (loss), net [2] 35,690     35,690      
Share-based compensation expense 16,567   16,567        
Restricted share grants ( in shares)   4,682,000          
Restricted share grants 0 $ 47 (47)        
Performance stock units settled, net of withholdings (in shares)   97,000          
Performance stock units settled, net of withholdings (126) $ 1 (127)        
Issuance of common stock (in shares)   490,000          
Issuance of common stock 100 $ 5 95        
Treasury stock (in shares)           1,132,000  
Treasury stock (2,642)         $ (2,642)  
Restricted share forfeiture (in shares)           1,420,000  
Restricted share forfeiture (14)         $ (14)  
Other activity 259   259        
Ending balance (in shares) at Dec. 31, 2023   158,555,000          
Ending balance at Dec. 31, 2023 317,313 $ 1,586 1,426,325 (65,541) (1,027,192) $ (17,393) (472)
Ending balance (in shares) at Dec. 31, 2023           9,615,000  
Increase (Decrease) in Stockholders' Equity              
Net income (loss) attributable to USA TODAY Co. (26,387)       (26,354)   (33)
Other comprehensive income (loss), net [2] 9,377     9,377      
Share-based compensation expense 12,522   12,522        
Equity component of convertible debt (157,089)   (157,089)        
Issuance of common stock (in shares)   281,000          
Issuance of common stock 99 $ 2 97        
Treasury stock (in shares)           1,289,000  
Treasury stock (3,141)         $ (3,141)  
Restricted share forfeiture (in shares)           543,000  
Restricted share forfeiture (6)         $ (6)  
Other activity $ (54)   (54)        
Ending balance (in shares) at Dec. 31, 2024 147,388,555 158,836,000          
Ending balance at Dec. 31, 2024 $ 152,634 $ 1,588 1,281,801 (56,164) (1,053,546) $ (20,540) (505)
Ending balance (in shares) at Dec. 31, 2024 11,447,187         11,447,000  
Increase (Decrease) in Stockholders' Equity              
Net income (loss) attributable to USA TODAY Co. $ 1,755       1,749   6
Other comprehensive income (loss), net [2] (2,741)     (2,741)      
Share-based compensation expense 9,149   9,149        
Restricted stock awards settled, net of withholdings (in shares)   512,000          
Restricted stock awards settled, net of withholdings (1,069) $ 5 (1,074)        
Performance stock units settled, net of withholdings (in shares)   232,000          
Performance stock units settled, net of withholdings (520) $ 3 (523)        
Equity component of convertible debt (2,043)   (2,043)        
Issuance of common stock (in shares)   332,000          
Issuance of common stock 173 $ 3 170        
Treasury stock (in shares)           965,000  
Treasury stock (3,064)         $ (3,064)  
Restricted share forfeiture (in shares)           375,000  
Restricted share forfeiture (3)         $ (3)  
Other activity $ 341   341        
Ending balance (in shares) at Dec. 31, 2025 147,124,756 159,912,000          
Ending balance at Dec. 31, 2025 $ 154,612 $ 1,599 $ 1,287,821 $ (58,905) $ (1,051,797) $ (23,607) $ (499)
Ending balance (in shares) at Dec. 31, 2025 12,787,396         12,787,000  
[1] (a) Excludes Redeemable noncontrolling interests which are reflected in temporary equity.
[2] (b) Other comprehensive (loss) income is net of an income tax benefit of $5.6 million for the year ended December 31, 2025 and net of an income tax provision of $2.9 million and $6.8 million for the years ended December 31, 2024 and 2023, respectively.